Supraspinatus Tendinitis

3

Review clinical trials related to Supraspinatus Tendinitis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

HILT vs ESWT in Supraspinatus Tendinitis

This randomized controlled trial aims to compare the effectiveness of High-Intensity Laser Therapy (HILT) and Extracorporeal Shock Wave Therapy (ESWT) in patients with supraspinatus tendinitis.

Participants needed: 48
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Kafrelsheikh UniversityUpdated: May 29, 2026
Eligibility criteria

Male and female participants aged between 18 and 60 years. [+4]

Full-thickness rotator cuff tear. [+7]

Status: Not yet recruiting

Effect of Ozonated Gel Phonophoresis on Pain and Functional Disability in Patients With Chronic Supraspinatus Tendinitis

This study will be conducted to investigate the effect of ozonated gel phonophoresis on pain intensity, shoulder joint range of motion, and functional disability in patients with chronic supraspinatus tendinitis grades I and II.

Participants needed: 40
Trial details
Age: 30-60Biological sex: AllType: InterventionalSponsor: Cairo UniversityUpdated: Jan 5, 2026Locations: 1
Eligibility criteria

Patients from 30-60 years old from both genders. [+3]

Grades III of supraspinatus tendinitis. (Bone spurs and tendon rapture) [+10]

Status: Not yet recruiting

Effect of TECAR (Transfer of Energy Capacitive and Resistive) Therapy on Chronic Supraspinatus Tendinitis

This study aims to investigate the effect of TECAR therapy on pain, shoulder range of motion, functional disability, and handgrip strength in patients with grade II supraspinatus tendinitis.

Participants needed: 46
Trial details
Age: 30-55Biological sex: AllType: InterventionalSponsor: Cairo UniversityUpdated: Jan 5, 2026Locations: 1
Eligibility criteria

Supraspinatus Tendinitis grade II based on Neer's classification, confirmed by s... [+1]

Other grades of Supraspinatus Tendinitis. [+10]